Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

109 results about "Tissue trauma" patented technology

Tissue trauma: Severe systemic manifestation of trauma and ischemia involving soft tissues, principally skeletal muscle, due to prolonged severe crushing.

Medical device

The present invention relates to the use of a gene transfer product to reduce hyperplastic connective tissue growth after tissue trauma or implantation of a medical device. The present invention also relates to a medical device with improved biological properties for an at least partial contact with blood, bodily fluids and / or tissues when introduced in a mammalian body, which device comprises a core and a nucleic acid, encoding a product capable of leading to production of extracellular superoxide dismutase present in a biologically compatible medium. Said nucleic acid encodes a translation or transcription product, which is capable of inhibiting hyperplastic connective tissue growth and promoting endothelialisation in vivo at least partially on a synthetic surface of said core. The present invention also relates to a method of producing a medical device according to the invention.
Owner:FIT BIOTECH OY PLC

Stent with outer slough coating

The stent with an outer slough coating 125 of the present invention provides a coated stent having a permanent coating 130 disposed on the stent and a slough coating 125 disposed on the permanent coating 130. The permanent coating 130 includes an anti-proliferative agent and the slough coating 125 includes an anti-inflammatory agent. The slough coating 125 erodes shortly after stent implantation to deliver the anti-inflammatory agent, which treats tissue trauma from the angioplasty and the presence of the stent. Once the slough coating 125 has substantially eroded, the permanent coating 130 delivers the anti-proliferative agent long-term to prevent tissue growth on the stent or within the body lumen, and prevent restenosis. The permanent coating 130 can also include an anti-inflammatory agent.
Owner:MEDTRONIC VASCULAR INC

Flexible visually directed medical intubation instrument and method

A flexible medical intubation instrument provided for placement into an animal or human patient comprises a catheter with at least a pair of longitudinally extending lumens or channels including a sensor and/or actuator channel and a working channel. In the sensor/actuator channel is provided a fixed or slideably removable sensor cable having a sensor for sensing a characteristic or condition including any of the following: a visual sensor for optical viewing, a chemical sensor, a pH sensor, a pressure sensor, an infection sensor, an audio sensor, or a temperature sensor. The sensors are coupled by the sensor/actuator cable through light transmission, electric current, or radio transmission to a viewing instrument or other output device such as a meter or video screen for displaying the condition that is sensed within the body of the patient while the flexibility of the composite structure comprising the catheter and cable enable the entire instrument to flex laterally as it moves through curved passages or around obstructions during insertion or removal. While making observations through the sensor channel, the working channel simultaneously functions as a drain or an irrigation duct, a feeding tube, or to provide a passage for the insertion of one or a succession of surgical devices such that the catheter serves as a protective artificial tract or liner as surgical devices are inserted and removed through it in succession so as to minimize tissue trauma, infection, and pain experienced by the patient. The instrument can be used in urology, as well as a visually directed nasogastric tube, as a visually directed external gastrostomy tube, or as a visually directed internal gastric tube or percutaneous endoscopic gastrostomy tube and in other applications.
Owner:PERCUVISION

Apparatus and methods for removing vertebral bone and disc tissue

Tissue removal probes comprise an elongated member, a drive shaft rotatably disposed within the member, and a rotatably tissue removal element mounted to the distal end of the drive shaft. One tissue removal element comprises a plurality of tissue-cutting filaments affixed at proximal and distal ends of the tissue removal element. The cutting filaments may have optional hinge points that allow the distal end of the tissue removal element to be inverted, thereby transforming the tissue removal element from a tissue-cutting device to a tissue-grasping device. Another tissue removal element may have a blunted tip to prevent distal tissue trauma and an irrigation port to provide irrigation fluid to the removed tissue and / or tissue removal element. Another tissue removal element has a proximal and distal spiral grooves that are oppositely pitched, so that removed tissue can be collected in the middle of the tissue removal element. Another tissue removal element has independent counter-rotating tissue removal elements to maintain stability during a bone cutting procedure. Still another tissue removal element takes the form of a drill bit with fluted cutting grooves. Yet another tissue removal element has cascading tissue-cutting notches that can be reciprocatably moved to remove tissue within a hole.
Owner:BOSTON SCI SCIMED INC

Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan

InactiveUS20050147656A1Imparts complianceImparts flexibilityOrganic active ingredientsBiocideInlet channelHydrophilic polymers
Tissue dressing assemblies are formed from hydrophilic polymer sponge structures. The tissue dressing assemblies can be used, e.g., (i) stanch, seal, or stabilize a site of tissue injury, tissue trauma, or tissue access; or (ii) form an anti-microbial barrier; or (iii) form an antiviral patch; or (iv) intervene in a bleeding disorder; or (v) release a therapeutic agent; or (vi) treat a mucosal surface; or (vii) combinations thereof. The tissue dressing structures are made compliant, e.g., by (i) micro-fracturing of a substantial portion of the sponge structure by mechanical manipulation prior to use, or (ii) a surface relief pattern formed on a substantial portion of the sponge structure prior to use, or (iii) a pattern of fluid inlet channels formed in a substantial portion of the sponge structure prior to use, or (iv) the impregnation of a sheet material within the sponge structure.
Owner:HEMCON MEDICAL TECH

Flexible visually directed medical intubation instrument and method

A flexible medical intubation instrument provided for placement into an animal or human patient comprises a catheter with at least one longitudinally extending lumen or channel. A fixed or slideably removable sensor cable is at least partially contained within the channel, having a sensor for sensing a characteristic or condition. While enabling observations through the sensor channel, the working channel may simultaneously function as a drain or an irrigation duct, a feeding tube, or to provide a passage for the insertion of one or a succession of surgical devices such that the catheter serves as a protective artificial tract or liner as surgical devices are inserted and removed through it in succession so as to minimize tissue trauma.
Owner:PERCUVISION

Novel non-selective cation channel in neuronal cells and methods for treating brain swelling

The present invention is directed to therapeutic compounds, treatment methods, and kits affecting the NCCa-ATP channel of neural tissue, including neurons, glia and blood vessels within the nervous system, and methods of using same. The NCCa-ATP channel is newly expressed in neural tissue following injury such as ischemia, and is regulated by the sulfonylurea receptor SUR1, being inhibited by sulfonylurea compounds, e.g., glibenclamide and tolbutamide, and opened by diazoxide. Antagonists of the NCCa-ATP channel, including SUR1 antagonists, are useful in the prevention, diminution, and treatment of injured or diseased neural tissue, including astrocytes, neurons and capillary endothelial cells, that is due to ischemia, tissue trauma, brain swelling and increased tissue pressure, or other forms of brain or spinal cord disease or injury. Agonists of the NCCa-ATP channel may be are useful in the treatment neural tissue where damage or destruction of the tissue, such as a gliotic capsule, is desired.
Owner:U S GOVERNMENT REPRESENTED BY THE DEPT OF VETERANS AFFAIRS

Method and apparatus for generating a tool path for a robotic orthopedic surgical procedure

ActiveUS20130035690A1Minimizes soft tissue traumaMinimizing required surgical accessMedical simulationMechanical/radiation/invasive therapiesComputer scienceSoft tissue
A method for generating an improved tool path for cutting a bone so as to minimize soft tissue trauma, wherein the method comprises:accessing an image of the bone which is to be cut;accessing an image of a pre-determined cutting pattern;superimposing the image of the pre-determined cutting pattern against the image of the bone;calculating the intersection of the pre-determined cutting pattern and the bone using the superimposed images of the pre-determined cutting pattern and the bone; andgenerating a tool path based upon the intersection of the pre-determined cutting pattern and the bone so as to minimize soft tissue trauma by leaving a thin perimeter of bone at the boundary of the bone cut when the boundary of the bone cut is adjacent to a bone surface.
Owner:THINK SURGICAL

Apparatus and methods for removing vertebral bone and disc tissue

Tissue removal probes comprise an elongated member, a drive shaft rotatably disposed within the member, and a rotatable tissue removal element mounted to the distal end of the drive shaft. One tissue removal element comprises a plurality of tissue-cutting filaments affixed at proximal and distal ends of the tissue removal element. The cutting filaments may have optional hinge points that allow the distal end of the tissue removal element to be inverted, thereby transforming the tissue removal element from a tissue-cutting device to a tissue-grasping device. Another tissue removal element may have a blunted tip to prevent distal tissue trauma and an irrigation port to provide irrigation fluid to the removed tissue and / or tissue removal element. Another tissue removal element has a proximal and distal spiral grooves that are oppositely pitched, so that removed tissue can be collected in the middle of the tissue removal element.
Owner:BOSTON SCI SCIMED INC

Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan

An antimicrobial barrier comprising a structure including a chitosan biomaterial. The antimicrobial barrier can be used, e.g., (i) stanch, seal, or stabilize a site of tissue injury, tissue trauma, or tissue access; or (ii) form an anti-microbial barrier; or (iii) form an antiviral patch; or (iv) intervene in a bleeding disorder; or (v) release a therapeutic agent; or (vi) treat a mucosal surface; or (vii) combinations thereof. The structure of the antimicrobial barrier may be densified by compression.
Owner:HEMCON MEDICAL TECH

Curette for deep pocket periodontal curettage

This invention relates to a periodontal instrument and curettage method for separating and removing calculus and diseased granulation tissue from the tooth surface and periodontal cavity in deep pockets greater than 10 mm. The invention is comprised of a straight shaft, a distal portion in parallel orientation with and terminating in a spoon-shaped blade with a rounded tip and continuous sharp edge. The approximate 90 degree angle orientation between the distal and proximal shank portions, rounded blade tip, and parallel alignment of the blade face relative to the distal shank portion enhance maneuverability, accessibility, and efficiency and minimize tissue trauma during periodontal curettage.
Owner:GARFINKEL LEONARD M

Electrical connector for cardiac devices

An electrical connector for a cardiac device is disclosed. The connector has a wire and an electrode at the distal end of the wire. The wire is attached to a patch, and the patch is coated with an adhesive film for adhering the patch to tissue. The preferred connector is a bipolar temporary cardiac pacing wire. The use of an adhesive film eliminates or reduces the need for suturing the patch to tissue, thus avoiding or significantly reducing tissue trauma associated with suturing.
Owner:ETHICON INC

Antagonists of a non-selective cation channel in neural cells

InactiveUS20100092469A1Reduce mortalityReduces stroke sizeBiocideNervous disorderDiseaseNervous system
The present invention is directed to a combination of therapeutic compounds and treatment methods and kits using the combination. In particular, one of the combination affects the NCca-ATP channel of neural tissue, including neurons, glia and blood vessels within the nervous system. Exemplary SUR1 and / or TRPM4 antagonists that inhibit the NCca-ATP channel may be employed in the combination. The combination therapy also employs one or more of a non-selective cation channel blocker and / or an antagonist of VEFG, NOS, MMP, or thrombin. Exemplary indications for the combination therapy includes the prevention, diminution, and / or treatment of injured or diseased neural tissue, including astrocytes, neurons and capillary endothelial cells, that is due to ischemia, tissue trauma, brain swelling and increased tissue pressure, or other forms of brain or spinal cord disease or injury, for example. In other embodiments, there are methods and compositions directed to antagonists of TRPM4, including at least for therapeutic treatment of traumatic brain injury, cerebral ischemia, central nervous system (CNS) damage, peripheral nervous system (PNS) damage, cerebral hypoxia, or edema, for example.
Owner:THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRS

Hemodialysis access system

A medical blood access system used for hemodialysis treatment to enable blood withdrawal for processing of blood by an external apparatus and return the same blood to a patient, comprising an interfacial fluid conduit between the machine and patient's blood supply which is repeatedly connectable along a guided pathway passing through epidermis and subcutaneous tissue via a naturally formed tissue tract to enter blood space, providing improved patient safely, convenience, effective prophylaxis, without bleeding or tissue trauma or pain, and is executable by the patient to precisely connect and disconnect with minimal disfigurement or life restrictions, and is useable on virtually all patients soon after placement and is robust and safe to high blood flow.
Owner:PROSL FRANK +2

Biopsy puncture auxiliary locator

The invention relates to a biopsy puncture auxiliary locator. The biopsy puncture auxiliary locator is characterized by comprising base plates which are matched with each other, a fixing plate, a locating pin reference plate, a rotating arm, a rotating sliding block, a sliding block gland and a guide pipe. The locating pin reference plate is arranged on the fixing plate, the base plates are magnetically connected to the locating pin reference plate, the rotating arm can rotate around the base plates, and the guide pipe is matched with the rotating sliding block and the sliding block gland and arranged on the rotating arm in a sliding mode. According to the biopsy puncture auxiliary locator, a doctor can perform a puncture operation fast and accurately, accuracy and stability are high, CT scanning is not needed again even if the body position of a patient moves inadvertently after location is finished, the locating position can be recovered just by overlapping an infrared reference line on the biopsy puncture auxiliary locator and CT infrared rays, repeated CT scanning and progressive needle insertion of a traditional puncture operation are avoided, operation safety is improved, operation time is shortened, radiation exposure caused by repeated roentgenoscopy is reduced, and tissue trauma and complications are reduced.
Owner:HANGZHOU SANTAN MEDICAL TECH

Focal Ablation Assembly

A focal ablation assembly, used with an endoscope comprising an endoscopic tube, comprises a cap and a cryogenic catheter placeable within the endoscopic tube channel. The cryogenic catheter defines a catheter lumen and has a distal end placeable at the endoscopic tube distal end. The cap is mountable to at least one of the distal ends and extends distally of both. The cap comprises a material which substantially maintains its shape during use while not causing tissue trauma. The cap defines a limited area therapeutic region, which is a chosen one of an open therapeutic region and a covered, effectively thermally transparent therapeutic region providing effectively no thermal insulation. In some examples the assembly includes a delivery catheter extending along the channel with a distal portion fluidly coupled to the cap volume, whereby refrigerant can be introduced into the cap volume and towards the therapeutic region by the delivery catheter.
Owner:PENTAX OF AMERICA

Apparatus and method for achieving micropuncture

InactiveUS20090187147A1Minimizing tissue traumaTrauma at the puncture site is substantially reducedGuide needlesGuide wiresDistal portionTissue trauma
A method comprises the steps of inserting a microneedle or micropuncture device into a body cavity to achieve a micropuncture into the cavity while reducing tissue trauma at a puncture site. A stepped or tapered guidewire having a reduced diameter distal portion is telescopically disposed through the inner diameter of the microneedle or Micropuncture device. A proximal portion of the guidewire has a diameter larger than the inner diameter of the microneedle or Micropuncture device and extends to a proximal end of the guidewire. The proximal portion is adapted for guiding a larger diameter instrument into and through the vascular system. The microneedle or micropuncture device is withdrawn from the micropuncture while leaving the distal portion of the guidewire extending through the micropuncture. The microneedle or micropuncture device is removed from the guidewire without removing the microneedle or Micropuncture device over the proximal end of the guidewire. As a result, tissue trauma at the puncture site is substantially reduced.
Owner:PRESSURE PROD MEDICAL SUPPLIES INC

Therapeutic Agents Targeting the NCCA-ATP Channel and Methods of Use Thereof

The present invention is directed to therapeutic compositions targeting the NCCa-ATP channel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, agonists and antagonists of the NCCa-ATP channel are contemplated. The therapeutic compositions are used to treat cancer, more specifically, a metastatic brain tumor, wherein a tumor-brain barrier is present. Such treatments are contemplated in combination with conventional anti-cancer therapies. Alternatively, the compositions are used to prevent cell death and to treat cerebral edema that result from ischemia, due to interruption of blood flow, to tissue trauma or to increased tissue pressure.
Owner:U S GOVERNMENT REPRESENTED BY THE DEPT OF VETERANS AFFAIRS

Method of Preventing or Reducing Scarring of Human Skin

InactiveUS20080182780A1Prevents and reduces formation of scar tissueIncrease speedBiocidePeptide/protein ingredientsHuman skinRe-epithelialisation
Insulin or a peroxisome proliferator-activated receptor (PPAR) agonist provides reliable and effective prevention of scarring in human skin, or at least a reduction in the severity of scarring. The application of insulin or the PPAR agonist to wounds topically or by local injection is particularly advantageous since it simultaneously reduces / prevents scarring whilst enhancing re-epithelialisation of the wound and thus provides a dual action wound healing treatment. The present invention accordingly provides a highly effective prophylactic treatment for any individual suffering tissue trauma to reduce and / or prevent normal and / or pathological scarring.
Owner:RAFT TRUSTEES

Wound dressing devices and methods

ActiveUS20100172958A1Stanch and seal and stabilize bleedingRigid enoughOrganic active ingredientsBiocideWound dressingD-Glucopyranose
The present invention provides an absorbent wound dressing assembly that can be used to stanch, seal, or stabilize a site of tissue injury, tissue trauma, or tissue access. The wound dressing assembly is flexible so that it can be adapted and used to fit in narrow and small wound sites. Generally the wound dressing assembly comprises a flexible carrier material that is impregnated with a non-mammalian material for control of severe bleeding. The preferred non-mammalian material is poly [β-(1→4)-2-amino-2-deoxy-D-glucopyranose] more commonly referred to as chitosan.
Owner:PROVIDENCE HEALTH SYST OREGON

Hemodialysis access system

A medical blood access system used for hemodialysis treatment to enable blood withdrawal for processing of blood by an external apparatus and return the same blood to a patient, comprising an interfacial fluid conduit between the machine and patient's blood supply which is repeatedly connectable along a guided pathway passing through epidermis and subcutaneous tissue via a naturally formed tissue tract to enter blood space, providing improved patient safely, convenience, effective prophylaxis, without bleeding or tissue trauma or pain, and is executable by the patient to precisely connect and disconnect with minimal disfigurement or life restrictions, and is useable on virtually all patients soon after placement and is robust and safe to high blood flow.
Owner:PROSL FRANK +2

Method of preventing or reducing scarring of human skin

InactiveUS20050054608A1Prevents and reduces formation of scar tissueIncrease speedBiocideOrganic active ingredientsHuman skinDual action
Insulin or a peroxisome proliferator-activated receptor (PPAR) agonist provides reliable and effective prevention of scarring in human skin, or at least a reduction in the severity of scarring. The application of insulin or the PPAR agonist to wounds topically or by local injection is particularly advantageous since it simultaneously reduces / prevents scarring whilst enhancing re-epithelialisation of the wound and thus provides a dual action wound healing treatment. The present invention accordingly provides a highly effective prophylactic treatment for any individual suffering tissue trauma to reduce and / or prevent normal and / or pathological scarring.
Owner:RAFT TRUSTEES

Wound dressing devices and methods

The present invention provides an absorbent wound dressing assembly that can be used to stanch, seal, or stabilize a site of tissue injury, tissue trauma, or tissue access. The wound dressing assembly is flexible so that it can be adapted and used to fit in narrow and small wound sites. Generally the wound dressing assembly comprises a flexible carrier material that is impregnated with a non-mammalian material for control of severe bleeding. The preferred non-mammalian material is poly [β-(1→4)-2-amino-2-deoxy-D-glucopyranose] more commonly referred to as chitosan.
Owner:PROVIDENCE HEALTH SYST OREGON

Medical retrieval device

ActiveUS9101383B1Increase pointsLimited degree of movementExcision instrumentsFlexible endoscopyEngineering
A medical retrieval basket used for entrapping and extracting objects such as urinary and biliary calculi from the body comprising a handle assembly, a flexible shaft, and a basket. The basket comprises a plurality of outwardly disposed shape memory wires and is bulbous in shape at its distal end. Located at the intersection point of the wires at the distal end of the basket is a hub that restricts the degree of relative movement between the wires. This hub also serves to increase contact points with the object to be retrieved and to stabilize the orientation of the basket wires. The substantially tipless configuration of the distal end of the basket permits the basket to retrieve objects from difficult to reach locations and reduces tissue trauma caused by the basket tip. The basket wires have varying cross sectional shapes and sizes in different sections of the basket to optimize the performance to the needs of each section within the basket. The flexible shaft contains a drive wire that exhibits different flexibilities within the same strand of material by varied cross sectional shapes or diameters. This permits the distal section of the shaft to be more flexible, which reduces the possibility of the device shaft limiting the deflection of a flexible endoscope.
Owner:ANNEX MEDICAL

Fairing for free scar instrument and method

The inventor provides a surgical device that performs surgery with minimal tissue trauma and is adapted to access the surgical site by a trocar having a plurality of cannulas or by a conventional trocar. The invention including: (a) a plurality of elongated rods, each including a proximal end and a distal end; (b) a holder; (c) a functional element; and (d) a fairing; wherein each said proximal end is connectable to said holder; wherein each said distal end is connectable to said functional element; wherein said fairing removably covers said plurality of elongated rods. Method are provided.
Owner:PEDREIRA DE CERQUEIRA FILHO LUIZ LANAT

Taurine-based compositions, therapeutic methods, and assays

Taurine and derivatives thereof may be used to repair the skin barrier, enhance hydration of the skin, prevent apoptosis and oxidative damage in the skin, and heal or prevent photo-induced skin damage. The presence of biogenic taurine or taurine derivatives in tissues and / or body fluids can be used as a biomarker for tissue trauma. Detection and / or quantification of such biogenic taurine or derivatives form the basis for an assay for determining the presence and / or extent of tissue damage.
Owner:LEVIS GEORGIA

Ultra-fine micropsy needle

A specimen retrieving needle is in the form of an elongated body having a closed lead end. At least one cutting blade may be formed on the body. The blade may have a sharpened edge so as to remove a specimen from an internal organ. The needle is ultrathin with an outside diameter of less than 1.0 mm to minimize tissue trauma and to reduce the risk of pain, hemorrhage and organ damage.
Owner:BRAUTIGAM ROBERT T +2

Methods for ameliorating tissue trauma from surgical incisions

Methods for ameliorating tissue trauma from a surgical incision comprise making the surgical incision with a cutting instrument comprising a cutting instrument body defining two opposed sides and a direction of elongation, and having at least one cutting edge extending along the direction of elongation. The cutting edge defines an ultimate edge and two beveled faces adjacent the ultimate edge. The cutting edge of the cutting instrument has at least one characteristic selected from the group consisting of (a) a uniform ultimate edge having a maximum height deviation of 4 m or less along any 680 m segment of thereof; (b) each beveled face having a maximum height deviation of 4 m or less along any 680 m segment of thereof; and (c) each beveled face adjacent the ultimate edge having a root mean square surface roughness (Rq) of not more than about 200 nm. Improved cutting instruments are also provided.
Owner:CABOT MICROELECTRONICS CORP

Novel non-selective cation channel in neuronal cells and method for treating brain swelling

The present invention is directed to therapeutic compounds, treatment methods, and kits affecting the NCCa-ATP channel of neural tissue, including neurons, glia and blood vessels within the nervous system, and methods of using same. The NCCa-ATP channel is newly expressed in neural tissue following injury such as ischemia, and is regulated by the sulfonylurea receptor SUR1, being inhibited by sulfonylurea compounds, e.g., glibenclamide and tolbutamide, and opened by diazoxide. Antagonists of the NCCa-ATP channel, including SUR1 antagonists, are useful in the prevention, diminution, and treatment of injured or diseased neural tissue, including astrocytes, neurons and capillary endothelial cells, that is due to ischemia, tissue trauma, brain swelling and increased tissue pressure, or other forms of brain or spinal cord disease or injury. Agonists of the NCCa-ATP channel may be are useful in the treatment neural tissue where damage or destruction of the tissue, such as a gliotic capsule, is desired.
Owner:UNIV OF MARYLAND

Scaffold device for preventing tissue trauma

InactiveUS20120203328A1Reduce and prevent traumaStentsCannulasMedical deviceTissue trauma
A scaffold is provided for managing access through tissue. The scaffold can support the tissue during medical procedures. The scaffold is placed around or proximate an opening in tissue. The scaffold can expand when medical devices are introduced through the scaffold and through the opening and retract when the medical devices are removed. When the medical devices are removed, the scaffold closes automatically to substantially close the opening.
Owner:ABBOTT CARDIOVASCULAR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products